Dr. Shifra Ash

EDUCATION

• 1978-1982 G. Weiss Life Science Faculty, Tel Aviv University, Tel Aviv, Israel

  Subject: Biology

  BSc degree

• 1980-1985 Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

  MD degree

  MD License No.:20153

• Oct 1992 Pediatrics Specialization Board Examinations
  Title of Doctoral Dissertation: Genetic linkage studies between F.M.F. and the Lipocortin genes

  Supervised by: Prof. M. Shoat, Prof. Y. Danon

  Specialist License No.: 20153

• Jun 1998 Pediatric Hematology-Oncology Specialization Board Examinations

  Specialist License No.: 20153

ACADEMIC & PROFESSIONAL ACTIVITIES & ACHIEVEMENTS

C1. Academic Experience:

• 2011 Lecturer to medical students, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
• 2019 Assisted Professor, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel

C2. Professional Experience:

• 1987-1992 Resident in Pediatrics, Rabin Medical Center – Beilinson Hospital, Petach Tikva, Israel
• 1992-1998 Fellowship in Pediatric Hematology-Oncology, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
• 1998-2000 Senior Physician, Pediatric Hematology-Oncology, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
• 2000-2001 Research in Dana Farber Cancer Institute, Boston, USA
• Since 2001 Senior Physician, Pediatric Hematology-Oncology, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
• Since 2011 Head of Day Care Unit, Pediatric Hematology-Oncology, Schneider Children’s Medical Center of Israel, Petach Tikva, Israel
• 2015 Head of ISPHO – Israel Society of Pediatric Hematology-Oncology

C3. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS

Date Country Name of Meeting Role
1993 Petach-Tikva, Israel Schneider, Conference Lecture
1999 Eilat, Israel Israeli-German Bi-National Conference Abstract
2000 San Francisco, USA ASH Poster
2001 Petach Tikva, Israel 2nd Research Conference, SCMCI 10th Anniversary Abstract
2002 Paris , France Advances in Neuroblastoma Research 11h Conference Poster
2002 Berlin, Germany 2nd Israeli-German Bi-National Conference on Current Concepts in Pediatric Oncology and Hematology Lecture
C3. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS

Date Country Name of Meeting Role
2004 Genoa, Italy Advances in Neuroblastoma Research 11th Conference Poster
2005 Herzelia, Israel ISPHO meeting Poster
2005 Magan, Israel ISPHO annual meeting Lecture
2005 Tel Aviv, Israel 6th Research Faire of Sackler Faculty of Medicine, TAU Poster
2006 LA, USA Advances in Neuroblastoma Research 12th Conference Poster-1
2006 LA, USA Advances in Neuroblastoma Research 12th Conference Poster-2
2007 Mumbai, India 39th Congress of the SIOP Lecture
2008 Chiba, Japan Advances in Neuroblastoma Research 13th Conference Poster
2008 Chiba, Japan Advances in Neuroblastoma Research 13th Conference Poster
2008 Mitzpe Ramon, Israel Annual Meeting of the Israel Pediatric Hematology & Oncology Society Lecture
2009 Ramot, Israel Annual Meeting of the ISPHO Lecture
2009 Stuttgart, Germany 22nd Annual Meeting of the European Musculo-Skeletal Oncology Society Poster-1
2009 Stuttgart, Germany 22nd Annual Meeting of the European Musculo-Skeletal Oncology Society Poster
2009 Tel Aviv, Israel ISCS 2nd International Meeting Poster
2009 Rome, Italy SIOPEN Annual General Meeting Lecture
2010 Ginosar, Israel Annual Meeting of the ISPHO Lecture
2010 Boston MA, USA 42nd Congress of the SIOP Lecture
2010 Boston MA, USA 42nd Congress of the SIOP Invited lecture
2010 Stockholm, Sweden Advances in Neuroblastoma Research 14th Conference Poster
2011 Auckland, New Zealand 43rd Congress of the SIOP Poster

C3. ACTIVE PARTICIPATION IN SCIENTIFIC MEETINGS

Date Country Name of Meeting Role
2012 Dead Sea, Israel Annual Meeting of the ISPHO Lecture
2013 Montevideo, Uruguay 3ras. Jornadas Latinoamericanas-Israelies de hemato-oncologia pediatrica, y en las Septoma Reunion Cientifica Annual Galop Invited lecture
2013 Washington DC, USA AACR Pediatric Annual Meeting Poster
2013 Canaan Spa Hotel, Safed, Israel TAU, Biennial retreat of the cancer biology research center Lecture
2014 Cologne, Germany Advances in Neuroblastoma Research 15th Conference Poster
2015 Chicago, IL, USA ASCO Annual Meeting Poster
2015 Tel Aviv, Israel The Israel Society for Clinical Laboratory Sciences Meeting lecture
2016 Queensland, Australia Advances in Neuroblastoma Research 16th Conference Poster
2016 Moscow, Russia 1st School of Diagnostics and Therapy of Embryonic Tumors Invited lecture
2017 Moscow, Russia 8th Meeting of the National Society of Pediatric Hematologists and Oncologists (NSPHO) Invited lecture
2017 Israel, Tel Aviv The 2nd International Meeting of Cardio-Oncology – Advancing cardiac care for cancer patients Invited lecture
2017 Washington, DC, USA 49nd Congress of the SIOP Poster
2017 Berlin, Germany AGM, SIOPEN meeting Lecture
2018 Sheba, Israel Sarcoma meeting lecture
2018 San Fransisco, USA ANR 2018 Poster
2018 Weizmann Institute of Science The Dwek Workshop on Children and Cancer Lecture
2018 Kyoto, Japan 50nd Congress of the SIOP Poster

C4. MEMBERSHIP IN PROFESSIONAL SOCIETIES

Name of Organization
1993 Israel Society of Clinical Pediatrics
1997 Israel Society of Hematology and Blood Transfusion
1995 Israel Society of Pediatric Hematology-Oncology
2007 International Society of Paediatric Oncology (SIOP)
2014 International European Society of Pediatric Oncology (SIOP-E)
2002 International Society of Paediatric Oncology Europe Neuroblastoma (SIOPEN)

D. DOCTORAL STUDENTS MENTORED BY CANDIDATE

Years (period) Name of Student Subject Academic Institute PhD/ MD In collaboration with
2016-2017 Barbara Raed High risk neuroblastoma TAU MD
2017 Ahmad Kabaha Extracranial germ cell tumors in the pediatric population – treatment and short and long term outcomes over 17 years –
A case control study (2000-2016) TAU MD Vered Shkalim

E. M.A./M.Sc Students

Years (period) Name of Student Subject Academic Institute MA/ MSc In collaboration with
2006-2009 Vered Gigi Immunotherapy for neuroblastoma using allogeneic hematopoietic stem cell transplant and adoptive transfer of dendritic cells to induce graft versus tumor reaction TAU MSc Dr. Ina Fabian
2010-2013 Inbal Mazal Immunotherapy for neuroblastoma using haploidentical hematopoietic stem cell transplant and adoptive transfer of dendritic cells to induce graft versus tumor reaction TAU MSc Prof. Itamar Shalit

F. GRANTS

2004 PI
Immunotherapy for neuroblastoma using allogeneic hematopoietic stem cell transplant and adoptive transfer of dendritic cells to induce graft versus tumor reaction
Granted by ICRF-2004
Total Amount: $25,000

2004-2006 PI
Immunotherapy to neuroblastoma using allogeneic bone marrow transplantation and dendritic cells
Granted by Israel Cancer Research Foundation
Total Amount: $50,000
F. GRANTS

2006-2008 PI
Immunotherapy for neuroblastoma: induction of graft versus tumor reaction by hematopoietic chimerism and tumor-sensitized dendritic cells.
Granted by the Israel Cancer Association
Total Amount: $50,000

2009 PI
Racheli Endowment Fund
Total Amount: $1,000

——————————————————————————————————–

2012 PI
The contribution of CD56 to the aggressiveness of Ewing sarcoma cells.
Granted by Israel Cancer Association
Total Amount: 22,500 NIS

G. AWARDS

2004 Global Investigator Research Fellowship, Advances in Neuroblastoma Research Meeting
——————————————————————————————————————

2016 The Danielle Sonnenfeld Foundation Prize, “Healing with a Heart”
Total Amount: 25,00 NIS

SCIENTIFIC PUBLICATIONS

B.1. ORIGINAL ARTICLES

B.1. Articles Published

1. Halevy J, Ash S.
Infectious mononucleosis in hospitalized patients over forty years of age.
Am J Med Sci. 1988;295(2):122-124.

2. Steinhertz R, Rachmel A, Josephsberg Z, Flasterstein B, Ben-Amitai D,
Zangen S, Ash S, Nitzan M.
Hydrocortisone resolves persistent neonatal jaundice in multiple hormone deficiencies.
Helv Paediatr Acta. 1988;43(3):219-223.

3. Ash S, Garty BZ.
Neutropenia induced by antibiotics in children with osteomyelitis.
International Pediatrics. 1992;7(4):331-334.

4. Johnson C, Shoat T, Schlesinger M, Ash S, Shohat M.
Further localization of the properdin deficiency gene to locus Xp11.3-p21.10.2017.
Genet. (Life Sci Adv.) 1992;11:235-237.

5. Ash S, Johnson C, Shohat M, Shohat T, Schlesinger M.
Further mapping of properdin deficiency gene in Tunisian Jewish family – evidence for genetic homogeneity.
Isr J Med Sci. 1994;30(8):626-628.

6. Stark B, Resnitzky P, Jeison M, Luria D, Blau O, Avigad S, Shaft D, Kodman Y, Gobuzov R, Ash S, Stein G, Yaniv I, Barak Y, Zaizov R.
A distinct subtype of M4/M5 acute myeloblastic leukemia (AML) associated with t(8:16)(p11:p13), in a patient with variant t(8:19)(p11:q13)-case report and review of the literature.
Leuk Res. 1995;19(6):367-369.
29/63 Hematology, 2.561.

7. Stark B, Mor C, Jeison M, Gobuzov R, Cohen IJ, Goshen Y, Stein J, Fisher S, Ash S, Yaniv I, Zaizov R.
Additional chromosome 1q aberrations and der(16)t(1;16), correlation to the phenotypic expression and clinical behavior of the Ewing family of tumors.
J Neuro-Oncol. 1997;31:3-8.
90/132 Oncology. 1.856.

B.1. Articles Published

8. Stark B, Jeison M, Gobuzov R, Kadishevitch Cohen IJ, Yaniv I, Goshen J, Tamary H, Ash S, Stein J, Fischer S, Zaizov R.
Cytogenetic subgroups in childhood acute myeloblastic leukemia (AML) in a national center of pediatric oncology department in Israel.
Acute Leukemia VI, Buchner et al. (Eds.) 44-53,1997.

9. Shuper A, Cohen IJ, Korenreich L, Mor C, Ash S, Zaizov R.
Metastatic brain involvement in Ewing family of tumors in children.
Neurology. 1998;51(5):1336-8.

10. Avigad S, Kuperstein G, Zilberstein J, Liberzon E, Stark B, Gelernter I, Kodman Y, Luria D, Ash S, Stein J, Goshen Y, Yaniv I, Cohen IJ, Zaizov R.
TEL–AML1 fusion transcript designates a favorable outcome with an intensified protocol in childhood acute lymphoblastic leukemia.
Leukemia. 1999;13:481-498.
6/63 Hematology. 6.924.

11. Yaniv I, Fischer S, Mor C, Kodman Y, Luria D, Stark B, Ash S, Goshen Y, Stein J, Cohen IJ, Zaizov R.
Improved outcome in childhood B-Cell Lymphoma with intensified French LMB protocol.
Med Pediatr Oncol. 2000;35:8-12.

12. Stark B, Jeison M, Gobuzov R, Finkelshtein S, Ash S, Avrahami G, Cohen IJ, Stein J, Yaniv I, Zaizov R, Bar-Am I.
Apparently unrelated clones shown by spectral karyotyping to represent clonal evolution of cryptic t(10;11)(p13;q23) in a patient with acute monoblastic leukemia.
Cancer Genet Cytogenet. 2000;120:105-110.
99/132 Oncology. 1.559.

13. Steinberg R, Freud E, Zer M, Ziperman I, Goshen Y, Ash S, Stein J, Zaizov R, Avigad S.
High frequency of loss of heterozygosity for 1p35-p36 (DIS247) in Wilm’s tumor.
Cancer Genet Cytogenet. 2000;117:136-139.

14. Karmazyn B, Ash S, Goshen Y, Yaniv I, Horev G, Kornreich L.
Significance of residual abdominal masses in children with abdominal Burkitt’s lymphoma.
Pediatr Radiol. 2001;31:801-805.
50/78 Pediatrics. 0.991.

B.1. Articles Published

15. Stark B, Jeison M, Glaser-Gabay L, Bar-Am I, Mardoukh J, Ash S, Atias D, Stein J, Zaizov R, Yaniv I.
der(11)t(11;17) a distinct cytogenetics pathway of advanced stage neuroblastoma – detected by SKY.
Cancer Lett. 2003;197:75-79.
49/132 Oncology. 3.398.

16. Yaniv I, Cohen IJ, Zilberstein J, Liberzon E, Atlas O, Grunshpan A,
Sverdlov Y, Ash S, Zaizov R, Avigad S.
Tumor cells are present in stem cell harvests of Ewing’s sarcoma patients and their persistence following transplantation predicts relapse.
Pediatr Blood Cancer. 2004;42(5):404-409.

17. Walach B, Ash S, Gavrieli R, Stark B, Yaniv I. Roos D.
Acute lymphoblastic leukemia in a patient with chronic granulomatous disease and a novel mutation in CYBB: first report.
Am J Hematol. 2005; 80(1):50-54.
36/63 Hematology. 1.949.

18. Fenig E, Mishaeli M, Yerushalmi R, Bar Sever Z, Ash S, Kornreich L, Yaniv I, Steinmetz A.
Treatment of neuroblastoma using the fused imaging guided radiotherapy (FIGURA) system.
Clin Nucl Med. 2006;31(5):256-8.
15/87 Radiology, Nuclear Medicine & Medical Imaging. 3.231.

19. Ohali A, Avigad S, Ash S, Goshen Y, Luria D, Feinmesser M, Zaizov R,
Yaniv I.
Telomere length is a prognostic factor in neuroblastoma.
Cancer. 2006;107(6):1391-9.
28/132 Oncology, 4.632.

20. Kravarusic D, Feigin E, Dlugy E, Steinberg R, Baazov A, Erez I, Lazar L, Kapuller V, Grunspan M, Ash S, Freud E.
Colorectal carcinoma in childhood: a retrospective multicenter study.
J Pediatr Gastroenterol Nutr. 2007;44(2):209-11.

21. Aviner S, Dabby D, London D, Feinmesser M, Ash S, Steinberg R, Jakim I.
Renal cell carcinoma in a child presented as bilateral femur neck fractures caused by severe vitamin D deficiency.
J Pediatr Hematol Oncol. 2007;29(12):848-50.

22. Ash S, Yaniv I, Goshen Y, Toledano H, Stein J, Horev G, Bar Sever Z, Fenig E, Iskob S, Avigad S, Cohen IJ, Sharon N.
[Changes in relapse pattern in Ewing sarcoma with an intensified treatment protocol, SCMCIE 94] [Hebrew]
Isr J Pediatr 2007;62:41.
B.1. Articles Published

23. Ohali API, Avigad SC, Naumov IC, Goshen YC, Ash SC, Yaniv IC
Different telomere maintenance mechanisms in alveolar and embryonal rhabdomyosarcoma.
Genes Chromosomes Cancer. 2008;47(11):965-70.
32/132 Oncology. 4.532.

24. Yolcu ESPI, Ash SC, Kaminitz AS, Sagiv YC, Askenasy NC, Yarkoni SC.
Apoptosis as a mechanism of T-regulatory cell homeostasis and suppression.
Immunol Cell Biol. 2008 Nov-Dec;86(8):650-8.

25. Ash S.
[Neuroblastoma- improvement in investigation and treatment strategies]. [Hebrew]
Isr J Pediatr. 2008;65:12-16.

26. Ash SPI, Gigi VS, Askenasy NC, Fabian IC, Stein JC, Yaniv IC
Graft versus neuroblastoma reaction is efficiently elicited by allogeneic bone marrow transplantation through cytolytic activity in the absence of GVHD.
Cancer Immunol Immunother. 2009;58(12):2073-84.
49/165 Oncology. 3.791.

27. Feinberg-Gorenshtein GS, Avigad SPI, Jeison MC, Halevy-Berco GT,
Mardoukh JT, Luria DC, Ash SC, Steinberg RC, Weizman AC, Yaniv IC
Reduced levels of miR-34a in neuroblastoma are not caused by mutations in the TP53 binding site.
Genes Chromosomes Cancer. 2009;48(7):539-43.
32/132 Oncology. 4.532.

28. Avigad SPI, Finberg GS, Luria DC, Jeison MC, Stein JC, Grunshpan AT,
Sverdlov YT, Ash SC, Yaniv IC.
Minimal residual disease in peripheral blood stem cell harvests from high-risk neuroblastoma patients.
J Pediatr Hematol Oncol. 2009;31(1):22-6.
52/63 Hematology. 1.278.

29. Yaniv IPI, Ash SC, Farkas DLC, Askenasy NPI, Stein JC.
Consideration of strategies for hematopoietic cell transplantation.
J Autoimmun. 2009;33(3-4):255-9.
13/128 Immunology. 7.231.

30. Ash SPI, Stein JC, Askenasy NC, Yaniv IC.
Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation.
Br J Cancer. 2010;103(10):1597-605.
35/166 Oncology. 4.346.

B.1. Articles Published

31. Jeison MPI, Ash SPI, Halevy-Berko GT, Mardoukh JT, Luria DC, Avigad SC,
Feinberg-Gorenshtein GC, Goshen Y, Hertzel GC, Kapelushnik JC, Ben Barak AC, Attias DC, Steinberg RC, Stein JC, Stark BC, Yaniv IC.
2p24 Gain region harboring MYCN gene compared with MYCN amplified and nonamplified neuroblastoma: biological and clinical characteristics.
Am J Pathol. 2010 Jun;176(6):2616-25.
22/71 Pathology. 2.673.

32. Schiller O, Ash S, Schonfeld T, Kadmon G, Nahum E, Yacobovich J,
Tamary H, Davidovits M.
Postoperative thrombotic thrombocytopenic purpura in an infant: case report and literature review.
J Pediatr Surg. 2011 Apr;46(4):764-6.
56/109 Pediatrics. 1.308.

33. Ash S, Luria D, Cohen IJ, Goshen Y, Toledano H, Issakov J, Yaniv I,
Avigad S.
Excellent prognosis in a subset of patients with Ewing sarcoma identified at diagnosis by CD56 using flow cytometry.
Clin. Cancer Res. 2011 May 1;17(9):2900-7
(Oncology 12/217, Q1, IF 9.619, Times Cited: 9)

34. Bonda-Shkedi E, Arush MW, Kaplinsky C, Ash S, Goshen Y, Yaniv I,
Cohen IJ.
The correlation between dose of Folinic Acid and neurotoxicity in children and adolescents treated for osteosarcoma with high-dose Methotrexate (HDMTX): A neuropsychological and psychosocial study.
J. Pediatr. Hematol. Oncol. 2013 May;35(4):271-5.
(Pediatrics 94/121, Q4, IF 1.076, Times Cited: 10)

35. Weyl Ben-Arus M, Ben Barak A, Bar-Deroma R, Ash S, Goldstein G, Golan H, Houri H, Waldman D, Nevo N, Bar Shalom R, Berniger A, Nevelsky A, Toren A, Yaniv I, Kuten A.
Targeted therapy with low doses of 131I-MIBG effective for disease palliation in highly refractory neuroblastoma.
Isr Med Assoc J. 2013 Jan;15(1):31-4.
(Medicine, General & Internal 98/155, Q3, IF 1.036, Times Cited: 1)

36. Gigi V, Stein J, Askenasy N, Yaniv I, Ash S.
Early immunization with dendritic cells after allogeneic bone marrow transplantation elicits graft vs tumor reactivity.
Br J Cancer. 2013 Mar 19;108(5):1092-9.
(Oncology 32/217, Q1, IF 6.176, Times Cited: 2)

B.1. Articles Published

37. Askenasy N, Ash S, Askenasy EM, Yaniv I, Stein J.
Depletion of naïve lymphocytes with fas ligand ex vivo prevents graft-versus-host disease without impairing T cell support of engraftment or graft-versus-tumor activity.
Biol Blood Marrow Transplant. 2013 Feb;19(2):185-95.
(Transplantation 3/25, Q1, IF 4.704, Times Cited: 12)

38. Yolcu ES, Kaminitz A, Mizrahi K, Ash S, Yaniv I, Stein J, Shirwan H,
Askenasy N.
Immunomodulation with donor regulatory T cells armed with Fas-ligand alleviates graft-versus-host disease.
Exp Hematol. 2013 Oct;41(10):903-11.
(Hematology 31/70, Q2, IF 2.82, Times Cited: 4)

39. Feinberg-Gorenshtein G, Guedj A, Shichrur K, Jeison M, Luria D, Kodman Y, Ash S, Feinmesser M, Edry L, Shomron N, Weizman A, Yaniv I, Avigad S.
miR-192 directly binds and regulates Dicer1 expression in neuroblastoma.
Plos One. 2013 Nov 1;8(11):e78713.
(Multidisciplinary Sciences 15/64, Q1, IF 2.806, Times Cited: 7)

40. Shichrur K, Feinberg-Gorenshtein G, Luria D, Ash S, Yaniv I, Avigad S.
Potential role of WSB1 isoforms in growth and survival of neuroblastoma cells.
Pediatr Res. 2014 Apr;75(4):482-6.
(Pediatrics 17/121, Q1, IF 2.882, Times Cited: 3)

41. Shalitin S, Laur E, Lebenthal Y, Ash S, Yaniv I, Philip M.
Endocrine complications and components of the metabolic syndrome in survivors of childhood malignant non-brain solid tumors.
Horm Res Paediatr. 2014;81(1):32-42.
(Pediatrics 54/121, Q2, IF 1.844, Times Cited: 3)

42. Mizrahi K, Yaniv I, Ash S, Stein J, Askenasy N.
Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts.
Bone Marrow Transplant. 2014 May;49(5):640-8.
(Hematology 20/70, Q2, IF 3.874, Times Cited: 5)

43. Mizrahi K, Ash S, Peled T, Yaniv I, Stein J, Askenasy N.
Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts.
Bone Marrow Transplant. 2014 Jul;49(7):942-9.
(Hematology 20/70, Q2, IF 3.874, Times Cited: 1)

B.1. Articles Published

44. Ash S, Yarkoni S, Askenasy N.
Lymphopenia is detrimental to therapeutic approaches to type 1 diabetes using regulatory T cells.
Immunol Res. 2014 Jan;58(1):101-5.
(Immunology 82/151, Q3, IF 2.905, Times Cited: 6)

45. Shichrur K, Feinberg-Gorenshtein G, Luria D, Ash S, Yaniv I, Avigad S.
Potential role of WSB1 isoforms in growth and survival of neuroblastoma cells. Pediatr Res.2014 Apr;75(4):482-6.
(Pediatrics 17/121, Q1, IF 2.882, Times Cited: 3)

46. Kaminitz A, Mizrahi K, Ash S, Ben-Nun A, Askenasy N.
Stable activity of diabetogenic cells with age in NOD mice: dynamics of reconstitution and adoptive diabetes transfer in immunocompromised mice.
Immunology. 2014 Jul;142(3):465-73.
(Immunology 54/151, Q2, IF 3.701, Times Cited: 5)

47. Hameiri-Grossman M, Porat-Klein A, Yaniv I, Ash S, Cohen IJ, Kodman Y, Haklai R, Elad-Sfadia G, Kloog Y, Chepurko E, Feinmesser M, Issakov J,
Sher O, Luria D, Kollender Y, Weizman A, Avigad S.
The association between let-7, RAS and HIF-1α in Ewing Sarcoma tumor growth.
Oncotarget. 2015 Oct 20;6(32):33834-48.
(Oncology 44/217, Q1, IF 5.168, Times Cited: 5)

48. Shkalim-Zemer V, Ash S, Toledano H, Kollender Y, Issakov J, Yaniv I,
Cohen IJ.
Highly effective reduced toxicity dose-intensive pilot protocol for non-metastatic limb osteogenic sarcoma (SCOS 89).
Cancer Chemother Pharmacol. 2015 Nov;76(5):909-16.
(Pharmacology & Pharmacy 112/257, Q2, IF 2.737, Times Cited: 1)

49. Abir R, Ben-Aharon I, Garor R, Yaniv I, Ash S, Stemmer SM, Ben-Haroush A, Freud E, Kravarusic D, Sapir O, Fisch B.
Cryopreservation of in vitro matured oocytes in addition to ovarian tissue freezing for fertility preservation in paediatric female cancer patients before and after cancer therapy.
Hum Reprod. 2016 Apr;31(4):750-62.
(Obstetrics & Gynecology 5/80, Q1, IF 5.02, Times Cited: 12)

B.1. Articles Published

50. Shkalim Zemer V, Toledano H, Ash S, Cohen E, Yaniv I, Cohen IJ.
Factors Affecting the Upper Limit of the Methotrexate (MTX) CSF Levels Achievable in Children With Brain Tumors Treated With High-dose Intravenous MTX.
Annual Meeting of the Israel Society of Pediatric Hematology Oncology (ISPHO), Ashkelon, Israel, 2015.
ISPHO Abstract book, 2015.
J Pediatr Hematol Oncol. 2016 Oct;38(7):544-8.
(Pediatrics 94/121, Q4, IF 1.076, Times Cited: 1)

51. Ben-Aharon I, Abir R, Perl G, Stein J, Gilad G, Toledano H, Elitzur S, Avrahami G, Ben-Haroush A, Oron G, Freud E, Kravarusic D, Ben-Arush M, Herzel G, Yaniv I, Stemmer SM, Fisch B, Ash S.
Optimizing the process of fertility preservation in pediatric female cancer patients – a multidisciplinary program.
BMC Cancer. 2016 Aug 9;16:620.
(Oncology 93/217, Q2, IF 3.288, Times Cited: 2)

52. Kaminitz A, Ash S, Askenasy N.
Neutralization Versus Reinforcement of Proinflammatory Cytokines to Arrest Autoimmunity in Type 1 Diabetes.
Clin Rev Allergy Immunol. 2017;52(3):460-472.
(Allergy 5/26, Q1, IF 5.263,Times Cited: 1)

53. Shkalim Zemer V, Toledano H, Kornreich L, Freud E, Atar E, Avigad S, Feinberg-Gorenshtein G, Fichman S, Issakov J, Dujovny T, Yaniv I, Ash S.
Sporadic desmoid tumors in the pediatric population: A single center experience and review of the literature.
J Pediatr Surg. 2017 Oct;52(10):1637-1641.
(Pediatrics 51/121, Q2, IF 1.976)

54. Trahair T, Sorrentino S, Russell SJ, Sampaio H, Selek L, Plantaz D,
Freycon C, Simon T, Kraal K, Beck-Popovic M, Haupt R, Ash S,
De Bernardi B.
Spinal Canal Involvement in Neuroblastoma.
J Pediatr. 2017 Sep;188:294-298.
(Pediatrics 7/121, Q1, IF 3.874)

55. Ash S, Yaniv I, Feinmesser R, Konen O, Feinmesser M.
Acinic Cell Carcinoma of the Parotid Gland in Children and Adolescents.
J Pediatr Hematol Oncol. 2018 Mar;40(2):99-103.
(Pediatrics 94/121, Q4, IF 1.076)

56. Séguier-Lipszyc E, Baazov A, Fichman S, Ash S, Freud E.
Current management of lipoblastoma.
Eur J Pediatr. 2018 Feb;177(2):237-241

57. Zmora O, Hayes-Jordan A, Nissan A, Kventsel I, Newmann Y, Itskovsky K, Ash S, Levy-Mendelovich S, Shinhar D, Ben-Yaakov A, Toren A, Bilik R.
Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for disseminated intraabdominal malignancies in children-a single-institution experience.
J Pediatr Surg.. 2018 Jul;53(7):1381-1386.
(Pediatrics 51/121, Q2, IF 1.976)

58. Oron G, Eitan R, Goldchmit C, Ash S, Rabinerson D, Garor R, Sapir O, Abir R, Yeoshoua E, Ben-Haroush A, Shufaro Y, Wiznitzer A, Fisch B.
Laparoscopically-assisted ultrasound-guided percutaneous transabdominal oocyte collection: fertility preservation in a 17-years-old girl with vaginal ewing sarcoma.
Harefuah. 2018 Jan;157(1):21-23.

59. Berbegall AP, Bogen D, Pötschger U, Beiske K, Bown N, Combaret V, Defferrari R, Jeison M, Mazzocco K, Varesio L, Vicha A, Ash S, Castel V, Coze C, Ladenstein R, Owens C, Papadakis V, Ruud E, Amann G, Sementa AR, Navarro S, Ambros PF, Noguera R, Ambros IM. Heterogeneous MYCN amplification in neuroblastoma: a SIOP Europe Neuroblastoma Study.
Br J Cancer. 2018 , May;118(11):1502-1512.
(Oncology 32/217, Q1, IF 6.176)

60. Morgenstern DA, Pötschger U, Moreno L, Papadakis V, Owens C, Burchill S, Ash S, Pasqualini C, Luksch R, Garaventa A, Canete A, Elliot M, Wieczorek A, Laureys G, Kogner P, Malis J, Ruud E, Beck-Popovic M, Schleiermacher G, Valteau-Couanet D, Ladenstein R.
Risk stratification of high-risk metastatic neuroblastoma: a report from the HR-NBL-1/SIOPEN study.
Pediatr Blood Cancer. 2018 Nov;65(11):

61. Elnekave E, Atar E, Amar S, Bruckheimer E, Knizhnik M, Yaniv I, Dujovny T, Feinmesser M, Ash S.
Doxorubicin-Eluting Intra-arterial Therapy for Pediatric Extra-Abdominal Desmoid Fibromatoses: A Promising Approach for a Perplexing Disease.
J Vasc Interv Radiol. 2018 Jul 31. pii: S1051-0443(18)31094-7

62. Siebert N, Troschke-Meurer S, Marx M, Zumpe M, Ehlert K, Gray J, Garaventa A, Manzitti C, Ash S, Klingebiel T, Beck J, Castel V, Valteau-Couanet D, Loibner H, Ladenstein R, Lode HN
Impact of HACA on immunomodulation and treatment toxicity following ch14.18/CHO long-term infusion with interleukin-2: results from a SIOPEN phase 2 trial
Cancers (Basel). 2018 Oct 17;10(10).

63. Barlevy D, Wangmo T, Ash S, Elger BS, Ravitsky V.
Oncofertility Decision Making: Findings from Israeli Adolescents and Parents.
J Adolesc Young Adult Oncol. 2018

64. Zeka F, Decock A, Van Goethem A, Vanderheyden K, Demuynck F, Lammens T, Helsmoortel HH, Vermeulen J, Noguera R, Berbegall AP, Combaret V, Schleiermacher G, Laureys G, Schramm A, Schulte JH, Rahmann S, Bienertová-Vašků J, Mazánek P, Jeison M, Ash S, Hogarty MD, Moreno-Smith M, Barbieri E, Shohet J, Berthold F, Van Maerken T, Speleman F, Fischer M, De Preter K, Mestdagh P, Vandesompele J.
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients.
JCI Insight. 2018 Dec 6;3(23). pii: 97021.

65. Ash S, Yaniv I, Toledano H, Stein J, Kollender Y, Fenig EI, Konen O,
Bar-Sever Z, Issakov J, Avigad S, Cohen IJ.
Improved outcome in local Ewing Sarcoma with an intensified pilot treatment protocol SCMCIE94.
J Pediatr Hematol Oncol. 2018.
(Pediatrics 94/121, Q4, IF 1.076)

66. Ben Shabat A, Ash S, Luckman J, Toledano H, Goldberg-Cohen N.
Likelihood of diagnosind Neuroblastoma in Isolated Horner Syndrome.
J Neurophthalmol. 2019

B.1. Articles Submitted

1.

“The no. of articles marked Q1 10 out of no. of total articles /articles from “line – drown” of last process 23 .”

מאמרים שפורסמו בעיתונים המדורגים כיום ברביע העליון (Q1) בתחומם, מאז המינוי האחרון

מס’ מאמר (כפי שמופיע ב-CV) שם העיתון שנת פרסום IF ו-Q
בשנת פרסום IF ו-Q
כיום
33. Clinical Cancer Research 2011 IF 7.742 Q1 IF 9.619 Q1
36. British Journal of Cancer 2013 IF 4.817 Q1 IF 6.176 Q1
37. Biology of Blood & Marrow Transplantation 2013 IF 3.348 Q2 IF 4.704 Q1
39. PLoS One 2013 IF 3.534 Q1 IF 2.806 Q1
40. Pediatric Research 2014 IF 2.314 Q1 IF 2.882 Q1
45. Pediatric Research 2014 IF 2.314 Q1 IF 2.882 Q1
47. Oncotarget 2015 IF 5.008 Q1 IF 5.168 Q1
49. Human Reproduction 2016 IF 5.02 Q1 IF 5.02 Q1
52. Clinical Reviews in Allergy & Immunology 2017 IF 5.263 Q1 IF 5.263 Q1
54. Journal of Pediatrics 2017 IF 3.874 Q1 IF 3.874 Q1

B.2. CASE REPORTS

B.2. Case Reports Published

1. Kuperman A, Kornreich L, Feinmesser M, Ash S, Yaniv I, Cohen IJ.
Regression of mesenchymal hamartoma of the liver with sarcoma chemotherapy.
Pediatr Hematol Oncol. 2013 Jan;35(1):e25-6.

B.3. REVIEW ARTICLES

B.3. Review Articles Published

1. Shemesh E, Yaniv I, Drucker M, Hadad S, Goshen Y, Stein J, Ash S, Fisher S, Zaizov R.
Home intravenous antibiotic treatment for febrile episodes in immune compromised pediatric patients.
Med Pediatr Oncol. 1998 Feb;30(2):95-100.

2. Cleper R, Davidovitz M, Krause I, Bar-Nathan N, Ash S, Schwarz M, Mor C,
Eisenstein B.
Unexpected Wilm’s tumor in a pediatric renal transplant recipient: suspected Denys-Drash syndrome.
Transplant Proc. 1999 Jun;31(4):1907-9.

3. Stark B, Jeison M, Preudhomme C, Fenaux P, Ash S, Korek Y, Stein J,
Zaizov R, Yaniv I.
Acquired trisomy 21 and distinct clonal evolution in acute megakaryoblastic leukemia in young monozygotic twins.
Br J Haematol. 2002 Sep;118:1082-6.

4. Postovsky S, Ash S, Ramu IN, Yaniv I, Zaizov R, Futerman B, Elhasid R,
Ben-Barak A, Halil A, Ben-Arush MW.
Central nervous system involvement in children with sarcoma
Oncology. 2003;65(2):118-24.

5. Avigad S, Cohen IJ, Zilberstein J, Liberzon E, Goshen Y, Ash S, Meller I,
Kollender Y, Issakov J, Zaizov R, Yaniv I.
The predictive potential of molecular detection in non-metastatic Ewing family of tumors.
Cancer. 2004 Mar 1;100(5):1053-8.

6. Avigad S, Naumov I, Ohali A, Jeison M, Halevy-Berco G, Mardoukh J, Stark B, Ash S, Cohen IJ, Meller I, Kollender Y, Issakov J, Yaniv I.
Short telomeres: a novel potential predictor of relapse in Ewing sarcoma.
Clin Cancer Res. 2007;13(19):5777-83.

B.3. Review Articles Published

7. Avigad S, Shukla S, Naumov I, Cohen IJ, Ash S, Meller I, Kollender Y,
Issakov J, Yaniv I.
Aberrant methylation and reduced expression of RASSF1A in Ewing sarcoma.
Pediatr Blood Cancer. 2009;53(6):1023-8.

8. Ash S, Luria D, Cohen IJ, Goshen Y, Toledano H, Issakov J, Yaniv I,
Avigad S.
Excellent prognosis in a subset of patients with Ewing sarcoma identified at diagnosis by CD56 using flow cytometry.
Clin Cancer Res. 2011 May 1;17(9):2900-7.

9. Jeison M, Yaniv I, Ash S.
Genetic stratification of neuroblastoma for treatment tailoring.
Future Oncol. 2011 Sep;7(9):1087-99.

—————————————————————————————————————

10. Ben-Aharon I, Ash S, Ben-Haroush A, Perl G, Oron G, Pinkas H, Freud N, Kravarusic D, Abir R, Sapir O, Wiznitzer A, Brenner B, Yaniv I, Stemmer S, Fisch B.
[Fertility preservation in young cancer patients – can we optimize the path?]
Harefuah. 2017 May;156(5):326-9.

Books
1. Ash S, Sorrentino S, Kraal K, De Bernardi B, Spinal canal involvement in peripheral neuroblastic tumors

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

1. Stark B, Jeison M, Gobuzov R, Cohen IJ, Goshen Y, Stein J, Fisher S, Ash S, Yaniv I, Mor C, Zaizov R.
The non-random cytogenetic aberrations in Ewing tumors in children – comparison to biological characteristics.
Annual Meeting of the Israel Society for Pediatric Hematology Oncology, Eilat, April 27-29, 1995.

2. Yaniv I, Fischer S, Mor C, Kodman Y, Luria D, Stark B, Ash S, Goshen Y, Stein J, Cohen IJ, Zaizov R.
Childhood B cell lymphoma – 20 years experience in Israel.
IX Meeting of the Mediterranean Blood Club, Cappadocia, Turkey, 9-11 September, 1995.

3. Fischer S, Yaniv I, Mor C, Kodman Y, Luria D, Stark B, Ash S, Goshen Y,
Stein J, Cohen IJ, Zaizov R.
Childhood B cell lymphoma – 20 years experience in Israel.
Annual Meeting of the Israeli Pediatric Hematology and Oncology Society Rosh Pina, Israel, March 1996.

4. Yaniv I, Ash S, Stark B, Stein J, Gavriel H, Cohen IJ, Zaizov R.
Childhood Acute Myeloid Leukemia – Consolidation with high dose Melphalan and autologous stem cell transplantation. A single center experience.
a. Marrow Transplantation in Children: Current Results and Controversies, Florida, USA, January 1997.
b. Israel Society of Hematology and Blood Transfusions Winter Meeting, Herzlia, Israel, February 1997.
c. 23rd Annual Meeting of the EBMT, Aix-les-Bains, France, March 23-27, 1997.

5. Ash S, Cohen IJ, Monovitz J, Avigad S, Mor C, Kollender Y, Meller I,
Chaison M, Goboziva R, Stark B, Goshen Y, Stein J, Tamary H, Avrahami G, Yaniv I, Peri T, Zaizov R.
Twenty-five years of treating Ewing family tumors: changes in the biological behavior.
Annual Meeting of the Israeli Pediatric Hematology and Oncology Society, Mitzpe Ramon, Israel, March 1997.

6. Yaniv I, Fischer S, Mor C, Kodman Y, Luria D, Vansover A, Ash S, Goshen Y, Stein J, Aviner S, Cohen IJ, Zaizov R.
High cure rate of childhood B cell lymphoma with a modified LMB protocol.
Annual Meeting of the Cancer Biology Research Center, Tiberias, Israel, May 1-3, 1997.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

7. Ash S, Cohen IJ, Mor S, Monovich Y, Avigad S, Kollender Y, Meller I,
Jeison M, Gobuziva R, Stark B, Goshen Y, Stein J, Tamary H, Avrahami G,
Yaniv I, Peri T, Zaizov R.
25 years experience in Ewing Sarcoma – The relevance of molecular and cytogenetic changes.
Annual Meeting of the Cancer Biology Research Center, Tiberias, Israel, May 1-3, 1997.

8. Stark B, Ash S, Avrahami G, Aviner S, Cohen I, Goshen Y, Gavriel H,
Luria D, Stein J, Tamary H, Yaniv I, Zaizov R.
T-cell lymphoma and T-cell leukemia at Schneider Children’s Medical Center of Israel (SCMCI). Last 12 years experience.
International Society of Pediatric Oncology (SIOP) XXIX Meeting, Istanbul, Turkey, September 23-27, 1997.
Med Pediatr Oncol. 1997;29(5):419A.

9. Yaniv I, Fischer S, Mor C, Kodman Y, Luria D, Vansover A, Ash S, Goshen Y, Stein Y, Aviner S, Cohen IJ, Zaizov R.
Childhood B cell lymphoma – a single center experience with a modified LMB protocol.
International Society of Pediatric Oncology (SIOP) XXIX Meeting, Istanbul, Turkey, September 23-27, 1997.

10. Yaniv I, Fischer S, Mor C, Kodman Y, Luria D, Vansover A, Stark B, Ash S,
Goshen Y, Stein J, Cohen IJ, Zaizov R.
Burkitt’s Lymphoma: 20 years experience in a Pediatric Oncology Center in Israel.
Israel Society of Hematology and Blood Transfusion Meeting, Eilat, Israel, October 22-24, 1998.

11. Stark B, Jeison M, Gobuzov R, …. Kadishevitch, Cohen IJ, Yaniv I, Goshen J, Tamary H, Ash S, Stein J, Fischer S, Zaizov R.
Cytogenetic subgroups in childhood acute myeloblastic leukemia at the Schneider Children’s Medical Center of Israel.
Acute Leukemia VI. 44,1997, 1998.

12. Stein J, Ben-Zvi N, Goshen Y, Ash S, Aviner S, Yaniv I.
High Dose Chemotherapy (HDC) and autologous stem cell rescue in children with neuroblastoma.
Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, Eilat, Israel, January 26-29,1999.
Abstract book, p.6.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

13. Stark B, Sakalik S, Mor C, Jeisson M, Bugovza R, Cohen IJ, Goshen Y,
Ash S, Stein J, Aviner S, Yaniv I, Zaizov R.
The biological significance of chromosome 1, 8, 16, aberrations detected by FISH in Ewing-family.
34th Annual Meeting of the American Society of Clinical Oncology, Los Angeles, CA, USA, May 1998.
ASCO Proceedings. 1998;17:536aA.

14. Aviner S, Korenreich L, Shuper A, Avrahami G, Ash S, Cohen IJ, Goshen Y, Stein J, Tamary H, Yaniv I, Zaizov R, Stark B.
Acute neurotoxicity in children with acute lymphoblastic leukemia and T cell lymphoma treated by the INS –89,93,98 (Mod ALL BFM –86,90,95) protocol at the SCMCI.
Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, Eilat, Israel, January 26-29,1999.
Abstract book, p.19.

15. Stark B, Cohen IJ, Sakalik S, Jeison M, Bugovza R, Mor C, Goshen Y, Ash S, Stein J, Aviner S, Yaniv I, Zaizov R.
Secondary chromosome 1,8,16 abnormalities in Ewing Family Tumors (EFT) detected by FISH.
Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, Eilat, Israel, January 26-29,1999.
Abstract book, p.30.

16. Avrahami G, Aviner S, Ash S, Stein J, Gabriel H, Goshen Y, Cohen IJ, Tamary H, Yaniv I, Zaizov R, Stark B.
Dose intensity and toxicity in children treated for ALL with the INS 89,93,98 (MOD BFM,86,90,95) At the SCMCI.
Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, Eilat, Israel, January 26-29,1999.
Abstract book, p. 54.

17. Ash S, Avrahami G, Aviner S, Goshen Y, Stein J, Yaniv I, Tamary H,
Cohen IJ, Zazov R, Stark B.
Outcome of the children with ALL relapse previously treated with the INS ’89,’93’,’98, (BFM Mod. ’86,90,’95) protocols at SCMCI.
Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, January 1999.
Abstract book, p. 50.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

18. Stark B, Jeison M, Bugovza R, Krug H, Avrahami G, Ash S, Aviner S, Stein J, Yaniv I, Zaizov R, Bar-Yam I.
Cryptic translocation t(10;11), jumping translocation and multiple subclones detected by spectral-karyotyping (SKY) in a child with acute aggressive monoblastic leukemia.
a. Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, Eilat, Israel, January 26-29,1999.
b. Annual Meeting of the Cancer Biology Research Center, Tel Aviv University, Haifa, Israel, February 1999.

19. Zaizov R, Cohen IJ, Monovitz J, Zilberstein J, Liberzon E, Mor C, Meller I, Kollender Y, Stark B, Yaniv I, Ash S, Stein J, Avigad S.
The clinical relevance of molecular diagnosis, staging and minimal residual disease in Ewing Sarcoma/PNET family of tumors.
Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, Eilat, Israel, January 26-29,1999.
Abstract book, p.11.

20. Ash S, Stein J, Goshen Y, Aviner S, Stark B, Avrahami G, Cohen IJ,
Tamary H, Zaizov R, Yaniv I.
Neuroblastoma in children under one-year of age – Schneider Children’s Medical center experience.
a. Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, Eilat, Israel, January 26-29,1999.
b. Conference of the Schneider Children’s Medical Center Felsenstein Medical Research Center, Petach Tikva, March 1999.
c. International Society of Pediatric Oncology (SIOP) Montreal, Canada, September 14-18,‏ 1999.
Israeli-German Bi-National Conference Abstract Book, p.28

21. Avigad S, Kuperstein G, Zilberstein J, Liberzon E, Stark B, Kodman Y, Luria D, Ash S, Stein J, Goshen Y, Yaniv I, Cohen IJ, Zaizov R.
TEL-AML1 fusion transcript designates a favorable outcome with an intensified protocol is childhood acute lymphoblastic leukemia.
a. Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, Eilat, Israel, January 26-29,1999.
b. Annual Meeting of the Cancer Biology Research Center, Tel Aviv University, Haifa, Israel, February 1999.
c. 2nd Research Conference, Schneider Children’s Medical Center of Israel – 10th anniversary, May 31, 2001.
Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology Abstract book, p.85.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

22. Goshen Y, Stark B, Blieden L, Berant M, Zafrir N, Ash S, Stein J, Cohen IJ,
Aviner S, Avrahami G, Zaizov R, Yaniv I.
The impact of reduced cumulative anthracyclines doses on cardiac function in the INS-89 protocol compared to the INS-84 protocol, in survivors of Acute Lymphoblastic Leukemia (ALL).
Israeli-German Bi-National Conference, Current Concepts in Pediatric Hematology-Oncology, Eilat, Israel, January 26-29,1999.
Abstract book. p.55.

23. Aviner S, Yaniv I, Ash S, Zaizov R, Tamary H.
Steroid treatment may reduce blood transfusions in hemolytic crisis of hereditary spherocytosis.
Conference of the Schneider Children’s Medical Center of Israel, Felsenstein Medical Research Center, Petach Tikva, March 8, 1999.

24. Yaniv I, Stein J, Tamary H, Ash S, Goshen Y, Cohen IJ.
A novel computer-based program for the management of Pediatric Hematology Oncology Centers.
Annual Meeting of International Society of Paediatric Oncology (SIOP), Montreal, Canada, September 14-18, 1999.

25. Goshen Y, Stein J, Cohen IJ, Stark B, Ash S, Tamary H, Avrahami G,
Aviner S, Zaizov R, Yaniv I.
Hodgkin’s lymphoma (HD) of childhood: Late effects of therapy.
International Society of Pediatric Oncology (SIOP), Montreal, Canada, September 14-18, 1999.

26. Avigad S, Liberzon E, Stark B, Ash S, Stein J, Cohen IJ, Yaniv I, Zaizov R.
The ATM gene is frequently involved in childhood T-cell lymphoblastic leukemia.
International Society of Pediatric Oncology (SIOP), Montreal, September 14-18, 1999.

27. Stark B, Jeison M, Gobozov R, Krug H, Avrahami G, Ash S, Aviner S, Stein J, Yaniv I, Zaizov R, Bar-Am I.
Cryptic translocation t(10;11) and multiple genetic subclones detected by spectral-karyotyping (SKY) in a child with acute aggressive monoblastic leukemia.
International Society of Pediatric Oncology (SIOP), Montreal, Canada, September 14-18,1999.
Abstract book, p. 60.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

28. Zaizov R, Liberzon E, Stark B, Ash S, Stein J, Cohen IJ, Yaniv I, Avigad S.
ATM mutations are involved in the leukemogenesis of childhood T cell Acute Lymphoblastic Leukemia.
a. 2nd Biennial Hannover Symposium on Childhood Leukemia and Lymphoma, Hannover, Germany, March 12-14, 2000.
b. Annual Meeting of the Israel Society of Pediatric Hematology Oncology (ISPHO), The Dead Sea, Israel, 16-18 March 2000.

29. Stark B, Jeisson M, Ash S, Korek Y, Stein J, Zaizov R, Yaniv I.
Acute megakaryoblastic leukemia with acquired trisomy 21 (in utero?) and with a distinct clonal evolution in young normal monozygotic twins.
3rd Biennial Hannover Symposium on Childhood Leukemia, Hannover, Germany, February 24-26, 2002.
Abstract book 2002.

30. Stark B, Jeisson M, Ash S, Stein J, Zaizov R, Yaniv I.
The prenatal origin (?) of acute megakaryoblastic leukemia with acquired trisomy 21 in normal monozygotic twins.
2nd Israeli-German Bi-National Conference on Current Concepts in Pediatric Oncology and Hematology, Berlin, Germany, November 20-21, 2002.

31. Bar-Sever Z, Steinmetz A, Fenig E, Mishaeli M, Ash S, Yaniv I.
The impact of image fusion on radiotherapy given to children with neuroblastoma: preliminary experience.
2nd Israeli-German Bi-National Conference on Current Concepts in Pediatric Oncology and Hematology, Berlin, Germany, November 20-21, 2002.

32. Ash S, Neuberg D, Donovan J, Temel J, Zuckerman A, Zuckerman D, Gribben J, Diller L.
Detection of Minimal Residual Disease by Real Time PCR Quantitation of Gage Expression in Neuroblastoma.
2nd Israeli-German Bi-National Conference on Current Concepts, in Pediatric Oncology and Hematology, Berlin, Germany, November 20-21, 2002.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

33. Yaniv I, Stein J, Ash S, Avrahami G, Goshen Y, Cohen IJ, Stark B.
High dose melphalan followed by autologous stem cell transplantation for childhood acute myeloid leukemia.
2nd Israeli-German Bi-National Conference Current Concepts in Pediatric Oncology and Hematology, Berlin, Germany, 2002.
Abstract book, p. 1279.

34. Stark B, Jeison M, Bar-Am I, Glaser-Gabay IL, Mardoukh J, Goshen Y, Ash S, Stein J, Zaizov R, Yaniv I.
Distinct cytogenetic pathways of advanced stage neuroblastoma detected by spectral karyotyping.
2nd Israeli-German Bi-National Conference Current Concepts in Pediatric Oncology and Hematology, Berlin, Germany, 2002.
Abstract book, p. 1282.

35. Yaniv I, Jeison M, Bar-Am I, Glaser-Gabay L, Mardoukh J, Goshen Y, Ash S, Stein J, Zaizov R, Stark B.
Distinct cytogenetic pathways of advanced stage neuroblastoma detected by spectral karyotyping.
Proc Am Soc Clin Oncol. 2003;22:3241A.

36. Shuper A, Ash S, Sadeh M, Gothelf D, Cohen IJ, Yaniv I.
“Dancing eye syndrome”: Good tumoral outcome, poor neurodevelopmental prognosis.
Annual Meeting of the Israel Society of Pediatric Hematology Oncology (ISPHO), Eilat, Israel, March 18-19, 2004.
ISPHO Abstract book, 2004.

37. Cohen IJ, Ash S, Goshen Y, Boneda E, Berant M, Meller I, Isaakov J, Buchvall I, Kollender Y, Yaniv I.
The impact of treatment for Osteosarcoma on long term survivors with therapy of increasing dosage and dose intensity.
Annual Meeting of the American Association of Clinical Oncology, San Diego, USA, June 5-8, 2004.

38. Ash S, Stein J, Goshen Y, Kornreich L, Bar-Sever Z, Feinmesser M, Yaniv I.
13 cis-retinoic acid in children with high-risk neuroblastoma: Is more better?
Advances in Neuroblastoma Research 11th Conference, Genoa, Italy, June 16-19, 2004.
Abstract book, p. 98.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

39. Goshen Y, Stark B, Blieden L, Berant M, Zafrir N, Ash S, Stein J, Cohen IJ,
Avrahami G, Zaizov R, Yaniv I.
Impact of reduced dose of anthracyclines on cardiac function in survivors of childhood ALL and T-cell non Hodgkin’s Lymphoma (T-NHL).
8th International Conference on Long-Term Complications of Treatment of Children and Adolescents for Cancer, Ontario, Canada, June 25-26, 2004.

40. Avigad S, Ohali A, Cohen IJ, Ophir R, Horn-Saban S, Meller I, Kollender Y, Issakov J, Ash S, Goshen Y, Zaizov R, Yaniv I.
Molecular signatures predicting outcome in Ewing Sarcoma.
Israel Association for Clinical Pediatrics, Tel Aviv, Israel, February 2, 2005.

41. Goshen Y, Stark B, Blieden L, Berant M, Zafrir N, Ash S, Stein J, Cohen IJ,
Avrahami G, Zaizov R, Yaniv I.
The impact of reduced dose of anthracyclines on cardiac function in survivors of childhood ALL ant T-cell lymphoma (T-NHL).
Israel Society of Pediatric Oncology (ISPHO) Annual Meeting 2005, Magan, Israel, March 3-5, 2005.

42. Ohali A, Avigad S, Goshen Y, Ash S, Zaizov R, Yaniv I.
Alternative lengthening of telomeres (ALT) as a predominant mechanism of telomere maintenance in Embryonal Rhabdomyosarcoma.
a. Israel Society of Pediatric Oncology (ISPHO) Annual Meeting 2005, Magan, Israel, March 3-5, 2005.
b. 96th Annual Meeting 2005 of American Association for Cancer Research (AACR), Orange County, CA, USA, April 16-20, 2005.
c. 6th Research Fair of the Sackler Faculty of Medicine, Tel Aviv, April 20, 2005.

43. Yaniv I, Ohali A, Avigad S, Cohen IJ, Goshen Y, Ash S, Luria D,
Feinmesser M, Meller I, Issakov J, Zaizov R.
The clinical relevance of telomerase activity and telomere length in pediatric solid tumors.
2005 ASCO Annual Meeting, Orlando, Florida, USA, May 13-17, 2005.

44. Goshen Y, Cohen IJ, Ash S, Stein J, Zaizov R, Yaniv I.
Late effects of treatment in rhabdomyosarcoma (RMS).
SMS 2005 – International Sarcoma Meeting Stuttgart, Germany, June 15-17, 2005.

45. Avigad S, Ohali A, Cohen IJ, Ash S, Goshen Y, Meller I, Kollender Y,
Issakov J, Zaizov R, Yaniv I.
New biological markers predicting outcome in Ewing family of tumors.
SMS 2005 – International Sarcoma Meeting, Stuttgart, Germany, June 15-17, 2005.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

46. Ohali A, Avigad S, Goshen Y, Ash S, Zaizov R, Yaniv I.
Alternative lengthening of telomeres (ALT) as a predominant mechanism of telomere maintenance in embryonal rhabdomyosarcoma.
SMS 2005 – International Sarcoma Meeting, Stuttgart, Germany, June 15-17, 2005.

47. Ash S, Kornreich L, Goshen Y, Yaniv Y, Cohen IJ.
Anti-angiogenic scheduling of gemcitabine vinblastine carboplatin for relapsed and metastatic osteosarcoma: a new therapeutic option.
ISPHO meeting,Herzelia, Israel, 2005.
Abstract book 2005.

48. Yaniv I, Reshef-Ronen T, Ash S, Goshen Y, Jeison M, Stark B,
Noordenberg N, Avigad S.
Micro-RNA deletion in neuroblastoma: a possible alternative mechanism of MYCN overexpression.
a. 2006 ASCO Annual Meeting, Atlanta, Georgia, June 2-6, 2006.
b. Advances in Neuroblastoma Research 12th conference, LA, USA, June, 2006.
Abstract book, p. 47.

49. Ash S, Jeison M, Kapelushnik J, Ben Barak A, Attias D, Gavriel H, Luria D,
Goshen Y, Stein J, Yaniv I, Stark B.
MYCN-gain compared to MYCN amplified neuroblastoma: biological and clinical characteristics.
Advances in Neuroblastoma Research 12th conference, LA,USA, June, 2006.
Abstract book, p. 56.

50. Ash S, Shuper A, Schwartz M, Freud N, Yaniv I.
Paraneoplastic Limbic Encephalitis accompanying nodular Ganglioneuroblastoma – therapeutic dilemma.
Advances in Neuroblastoma Research 12th conference, LA, USA, June, 2006.
Abstract book, p. 138.

51. Shukla S, Naumov I, Hameiri-Grossman M, Cohen IJ, Ash S, Yaniv I,
Avigad S.
Methylation analysis of specific micro RNAs in Ewing sarcoma.
AACR Annual Meeting 2007, Los Angeles, USA, April 14-18, 2007.

52. Yaniv I, Naumov I, Ohali A, Jeison M, Halevy Berco G, Mardoukh J, Stark B, Ash S, Cohen I, Meller I, Kollender Y, Issakov J, Avigad S.
Short telomeres: a novel potential predictor of relapse in Ewing sarcoma.
Pediatr Blood Cancer. 2007;49:410A.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

53. Jeison M, Ash S, Halevi-Barko G, Mardouk J, Kapelushnik J, Ben Barak A,
Attias D, Gavriel H, Luria D, Goshen Y, Stein J, Yaniv I.
MYCN-gain compared to MYCN amplified and non-amplified neuroblastoma: biological and clinical characteristics.
Annual Meeting of the Cancer Biology Research Center, Tel Aviv University, Ma’alot, Israel, April 26-28, 2007.

54. Hameiri-Grossman M, Avigad S, Cohen IJ, Ash S, Weizman A, Yaniv I.
Frequent deletions of specific micro-RNAs in Ewing sarcoma.
Annual Meeting of the Cancer Biology Research Center, Tel Aviv University, Ma’alot, Israel, April 26-28, 2007.

55. Avigad S, Hameiri-Grossman M, Cohen IJ, Ash S, Weizman A, Yaniv I.
microRNA analysis identified the involvement of RAS pathway in Ewing sarcoma tumors.
American Association for Cancer Research Meeting – the Role of Non-Coding RNAs in Cancer, Cambridge, Massachusetts, USA, October 31 – November 3, 2007.

56. Ash S, Finberg G, Avigad S, Grunshpan A, Goshen Y, Stein J, Yaniv I.
Evaluation of tyrosine hydroxylase (TH) expression in stem cell harvests for detection of contaminating Neuroblastoma cells.
39th Congress of the International Society of Paediatric Oncology (SIOP), Mumbai, India, November 1-3, 2007.
Pediatr Blood Cancer. 2007;49:501A.

57. Yaniv I, Naumov I, Ohali A, Jeison M, Halevy Berco G, Mardoukh J, Stark B, Ash S, Cohen I, Meller I, Kollender Y, Issakov J, Avigad S.
Short telomeres: a novel potential predictor of relapse in Ewing sarcoma.
39th Congress of the International Society of Paediatric Oncology (SIOP), Mumbai, India, November 1-3, 2007.

58. Goshen Y, Stark B, Cohen IJ, Ash S, Michowiz S, Kornreich L, Yaniv I.
How should we follow long term survivors of pediatric cancer after cranial irradiation?
39th Congress of the International Society of Paediatric Oncology (SIOP), Mumbai, India, November 1-3, 2007.
Pediatr Blood Cancer. 2007;49:547A.

59. Ash S, Yaniv I, Goshen Y, Toledano H, Stein J, Meller I, Kollender Y,
Horev G, Bar-Sever Z, Fenig E, Issakov J, Cohen I.
Changes in relapse pattern in Ewing Sarcoma with an intensified treatment protocol, SCIMCIE 94.
39th Congress of the International Society of Paediatric Oncology (SIOP), Mumbai, India, November 1-3, 2007.
Pediatr Blood Cancer. 2007;49:411A.
D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

60. Goshen Y, Ash S, Cohen IJ, Stein J, Yaniv I.
Fertility in survivors of Rhabdomyosarcoma.
Pediatr Blood Cancer. 2007;49:553A.

61. Ash S, Gigi V, Stein J, Yaniv I.
Allogeneic bone marrow transplants are significantly better than autologous transplants in treatment of murine neuroblastoma
a. Advances in Neuroblastoma Research 13th conference, Chiba, Japan, May 2008.
b. E-SIOP Neuroblastoma Annual Meeting, Lausanne, Switzerland, October 2008.
Adv Res Neuroblastoma Res Abstract book, p. 152.

62. Yaniv I, Hameiri-Grossman M, Luria D, Cohen IJ, Ash S, Kloog Y, Haklai R,
Weizman A, Avigad S.
Micro-RNA analysis revealed the RAS pathway to be involved in Ewing sarcoma: biological and clinical implications.
40th Congress of the International Society of Paediatric Oncology, Berlin, Germany, October 2-6, 2008.
Pediatr Blood Cancer. 2008;53(5):85A.

63. Porat A, Ohali A, Reshef-Ronin T, Cohen IJ, Ash S, Weizman A, Yaniv I,
Avigad S.
HIF-1a is overexpressed in Ewing sarcoma under normoxic conditions.
100th Annual Meeting of the American Association of Cancer Research (AACR), Colorado, Denver, USA, April 18-29, 2009.

64. Ash S, Halevy-Berko G, Avigad S, Mardoukh J, Luria D, Stein J, Stark B,
Yaniv I, Jeison M.
Molecular profiling of genetic changes by a multi-genomic approach for neuroblastoma subtyping and therapy stratification (multiplex ligation-dependent probe amplification – MLPA).
Annual Meeting of the Israeli Society of Pediatric Hematology/Oncology, Ramot, Israel, April 23-25, 2009.
Abstract book 2009.

65. Goshen Y, Kornreich L, Stein J, Ash S, Cohen IJ, Feinmesser M, Yaniv I.
Focal nodular hyperplasia of the liver following solid tumors in childhood.
a. Annual Meeting of the Israeli Society of Pediatric Hematology/Oncology, Ramot, Israel, April 23-25, 2009.
b. Annual Meeting of the Israel Society of Pediatric Hematology Oncology (ISPHO), Ginosar, Israel, April 28-30, 2010.
ISPHO, Ginosar Abstract book 2010.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

66. Cohen I, Miskin H, Leor R, Kuperman A, Ash S, Goshen Y, Toledano H,
Yaniv I.
Alfa-fetoprotein secreting hepatoblastoma – treatment by AFP levels further experience.
Annual Meeting of the Israeli Society of Pediatric Hematology/Oncology, Ramot, Israel, April 23-25, 2009.
Abstract book 2009.

67. Halevy-Berko G, Avigad S, Ash S, Feinberg-Gorenshtein G, Mardoukh J, Luria D, Stein J, Stark B, Yaniv I, Jeison M.
Molecular profiling of genetic changes by a multi-genomic approach for neuroblastoma subtyping and therapy stratification.
Annual Meeting of Cancer Biology Research Center, Tel Aviv University, Maalot, Israel, May 7-9, 2009.

68. Ash S, Kachko L, Katz J, Mukamel M, Weigel D, Kornreich L, Feinmesser M, Yaniv I.
Interferon α-2b treatment for childhood primary and recurrent hemangioendothelioma of bone.
22nd Annual Meeting of the European Musculo-Skeletal Oncology Society, Stuttgart, Germany, May 13-16, 2009.
Abstract book, p.90.

69. Ash S, Cohen I, Goshen Y, Toledano H, Yaniv I.
Fertility in female survivors of non metastatic osteosarcoma.
a. 22nd Annual Meeting of the European Musculo-Skeletal Oncology Society, Stuttgart, Germany, May 13-16, 2009.
Abstract book, p. 178.
b. Annual Meeting of the Israel Society of Pediatric Hematology Oncology (ISPHO), Ginosar, Israel, April 28-30, 2010.
ISPHO, Ginosar Abstract book, 2010.

70. Goshen Y, Kornreich L, Stein J, Ash S, Cohen IJ, Feinmesser M, Yaniv I.
Focal nodular hyperplasia of the liver following solid tumors in childhood.
22nd Annual Meeting of the European Musculo-Skeletal Oncology Society, Stuttgart, Germany, May 13-16, 2009.
Abstract book, p. 170.

71. Gigi V, Binkovsky N, Stein J, Yaniv I, Ash S.
Neuroblastoma is preferentially targeted by bone marrow-derived immune cells following allogeneic bone marrow transplantation.
ISCS Second International Meeting, Tel Aviv, Israel, May 27-29, 2009.

72. Ash S, Yaniv I.
Immunogenicity of neuroblastoma –the insight from an experimental model.
SIOPEN Annual General Meeting, Rome, Italy, October 26-28 2009.
D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

73. Yaniv I, Porat A, Reshef-Ronen T, Cohen IJ, Ash S, Kloog Y, Haklai R, Weizman A, Avigad S.
HIF-1α IS overexpressed in Ewing Sarcoma under normoxic conditions.
41st Congress of the International Society of Paediatric Oncology, Sau Paulo, Brazil, October 6-9, 2009.

74. Stein J, Askenasy N, Krauss A, Yakoni S, Ash S, Yaniv I.
Targeted depletion of cells expressing the IL-2/caspace chimeric protein.
36th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT), Vienna, Austria, March 21-25, 2010.

75. Abir R, Feinmesser M, Avigad S, Fisch B, Cohen IJ, Ash S, Ben-Haroush A, Meirow D, Felz C, Yaniv I.
Occasional involvement of the ovary in Ewing sarcoma.
a. Annual Meeting of the Israel Society of Pediatric Hematology Oncology (ISPHO), Ginosar, Israel, April 28-30, 2010.
b. 42nd Congress of the International Society of Paediatric Oncology (SIOP), Boston, Massachusetts, USA, October 21-24, 2010.
Pediatr Blood Cancer. 2010;55(5):874A.

76. Goshen Y, Cohen IJ, Stark B, Stein J, Ash S, Avrahami G, Feinmesser M, Yaniv I.
Thyroid carcinoma in survivors of childhood cancer.
Annual Meeting of the Israel Society of Pediatric Hematology Oncology (ISPHO), Ginosar, Israel, April 28-30, 2010.
ISDPHO, Ginosar Abstract book 2010.

77. Jeison M, Halevy-Berko G, Feinberg-Gorenshtein G, Itskovitch L, Ash S, Mardoukh J, Luria D, Stein J, Stark B, Avigad S, Yaniv I.
MLPA (Multiplex Ligation-dependent Probe Amplification) and FISH comparison/validation for genetic characterization of neuroblastoma.
Advances in Neuroblastoma Research (ANR), Stockholm, Sweden, June 21-24, 2010.
Abstract book, p. 190.

78. Ash S, Askenasy N, Yaniv I.
Immunogenicity of neuroblastoma – insights from experimental models.
Advances in Neuroblastoma Research (ANR), Stockholm, Sweden, June 21-24, 2010.
Abstract book, p. 148.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

79. Ash S.
Evaluation of bone marrow minimal dissemination disease in Ewing sarcoma using multiparametric flow cytometry.
42th Congress of the International Society of Paediatric Oncology (SIOP), Boston, USA, October, 2010.
Pediatr Blood Cancer. 2010;55(5):831A.

80. Ash S.
Allogeneic and haploidentical bone marrow transplants in neuroblastoma – lessons from a mouse model.
42th Congress of the International Society of Paediatric Oncology (SIOP), Boston, USA, October, 2010.

81. Beck Popvic M, Gracia E, Gross N, Combarat V, Ambros P, Beiske K,
Jenker A, Defachelles AS, Canete A, Brichard B, Balwierz W, Papadakis V, Ash S, Ruud E, Ladenstein, Ora I, Holmes K, De Bernardi B, Michon J, Mosseri V.
Characteristics of relapsing localized neuroblastoma: preliminary report of the second SIOPEN study (LNESG2, localized neuroblastoma European study group 2.
Advances in Neuroblastoma Research (ANR), Stockholm, Sweden, June 2010.
Abstract book, p. 124.

82. Ash A, Yaniv I, Feinmesser R, Konen O, Feinmesser M.
Acinic cell carcinoma of the parotid gland in children and adolescents – a possible association with thyroiditis.
a. 43th Congress of the International Society of Paediatric Oncology (SIOP), Auckland, New Zealand, October, 2011.
b. Annual Meeting of the Israel Society of Pediatric Hematology Oncology (ISPHO), Dead Sea, Israel, 2012.
Pediatr Blood Cancer. 2011;57(5):799A.
ISPHO Abstract book 2012.

83. Bar-Sever Z, Steinmetz A, Bernstine H, Ash S.
The significance of MIBG liver uptake in children with neuroblastoma.
Annual Meeting of the Israel Society of Pediatric Hematology Oncology (ISPHO), Dead Sea, Israel.
Abstract book, 2012.

84. Hameiri-Grossman M, Porat-Klein A, Cohen IJ, Ash S, Kloog Y, Haklai R, Elad-Sfadia G, Weizman A, Yaniv I, Avigad S.
Ras pathway and HIF-1 contribute to the aggressiveness of Ewing sarcoma.
American Association for Cancer Research (AACR) Pediatric Annual Meeting, Washington DC, USA, April 2013.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

85. Yaniv I, Feinberg-Gorenshtein G, Feinmesser M, Gaash D, Mirsky H,
Jeison M, Sharon NA, Ash S, Weizman A, Avigad IS.
miR-129-3p negatively regulates ALK in neuroblastoma and is associated with adverse prognosis.
AACR Pediatric Annual Meeting, Washington DC, USA, April 2013.

86. Ash S, Feinberg-Gorenshtein G, Feinmesser M, Gaash D, Mirsky H, Jeison M, Sharon NA, Weizman A, Yaniv I, Avigad S.
Towards personalized therapy in neuroblastoma
TAU, Biennial retreat of the cancer biology research center, Canaan Spa Hotel, Safed, Israel, June 2013

87. Yaniv I, Feinberg-Gorenshtein G, Feinmesser M, Gaash D, Mirsky H,
Jeison M, Sharon NA, Ash S, Weizman A, Avigad IS.
miR-129-3p expression may identify patients that could benefit from the addition of ALK inhibitors to their treatment protocols.
Congress of the International Society of Paediatric Oncology (SIOP), Hong Kong, China, September 2013.

88. Hameiri-Grossman M, Jeison M, Adam Sharon N, Mardoukh J, Luria D,
Ash S, Feinmesser M, Yaniv I, Avigad S.
Recurrent 14q32.33 gain including the genes: ADAM6 and KIAA0125 in neuroblastoma tumors.
Advances in Neuroblastoma Research (ANR), Cologne, Germany, May 2014.
Abstract book, p. 226.

89. Feinberg-Gorenshtein G, Feinmesser M, Gaash D, Mirsky H, Jeison M,
Adam Sharon N, Ash S, Yaniv I, Avigad S.
miR-129-3p directly binds and regulates ALK expression in neuroblastoma.
Advances in Neuroblastoma Research (ANR), Cologne, Germany, May 2014.
Abstract book p. 154.

90. Segura V, Alspach A, Di Cataldo A, Schleiermacher G, Bermudez JD,
Mosseri V, Papadakis V, Wheeler K, Castel V, Conte M, Ladenstein R, Schroder H, Plantaz D, Ash S, Brichard B, Canete A.
Non High-Risk Neuroblastoma European Strategy: SIOPEN LINES Protocol Implementation, Challenges, and Achievements.
Advances in Neuroblastoma Research (ANR), Cologne, Germany, May 2014.
Abstract book p. 246.

91. Ash S, Yaniv I, Steinmetz A, Bar-Sever Z.
The prognostic significance of MIBG uptake in left supraclavicular lymph nodes in high risk neuroblastoma patients.
ASCO Annual Meeting, Chicago, IL, USA, May 2015 .

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

92. Morgenstern DA, Ash S, Pötschger U, Wheeler K, Pasqualini C,
Valteau-Couanet D, Garaventa A, Papadakis V, Yaniv I, Ladenstein R.
Engraftment following busulfan/melphalan (BuMel) high-dose chemotherapy for high-risk neuroblastoma. A report from the HR-NBL-1/SIOPEN trial. (#326).
Advances in Neuroblastoma Research (ANR) Congress, Queensland, Australia, June 2016.
Abstract book, 2016.

93. Pasqualini C, Pötschger U, Ambros PF, Ash S, Morgenstern D, Di Cataldo A, Cañete A, Corrias M, Berlanga P, Castellani MR, Biassoni L, Balaguer J,
Kropf M, Schreier G, Schleiermacher G, Valteau-Couanet D, Ladenstein R.
Survival and prognostic factors for children 12 to 18 months of age with stage 4 non-MYCN amplified neuroblastoma treated in the SIOPEN high-risk trial (#168).
Advances in Neuroblastoma Research (ANR) Congress, Queensland, Australia, June 2016.
Abstract book 2016.

94. Ash S, Morgenstern D, Pötschger U, Yaniv I, Wheeler K, Pasqualini C,
Valteau-Couanet D, Garaventa A, Dallorso S, Papadakis V, Aleksandra W,
Berlanga P, Ladenstein R.
Analyzing risk factors for stem-cell collection failure in patients on the High-Risk Neuroblastoma 1 trial (HR-NBL1/SIOPEN) (#152).
Advances in Neuroblastoma Research (ANR) Congress, Queensland, Australia, June 2016.
Abstract book 2016.

95. Sorrentino S, Trahair T, Haupt R, Kraal K, Wieczorek A, Plantaz D, Owens C, De Bernardi B, Ash S.
Spinal canal invasion in peripheral neuroblastic tumors. Study design and preliminary results of a prospective SIOPEN Study Registry. (#333).
Advances in Neuroblastoma Research (ANR) Congress, Queensland, Australia, June 2016.
Abstract book 2016.

96. Moreno L, Pearson ADJ, Guo D, Morgenstern D, Pasqualini C, Ash S, Valteau-Couanet D, Cohn S, London WB.
Predicting “early” relapse/progression/death in children with INRGSS Stage M neuroblastoma using clinical and biologic factors: An INRG database analysis (#119).
Advances in Neuroblastoma Research (ANR) Congress, Queensland, Australia, June 2016.
Abstract book 2016.

D.2. PAPERS PRESENTED AT SCIENTIFIC MEETINGS PUBLISHED AS PROCEEDINGS and D. 3. ABSTRACTS

97. Ash S.
Epidural compression in neuroblastoma. Current therapeutic approaches.
1st School of Diagnostics and Therapy of Embryonic Tumors, November 25-26, 2016.
Abstract book 2017

98. Ash S, Haupt R, Kraal K, Plantaz D, Wieczorek A, Kachanov D, Owens C, Trager C, De Bernardi B, Gandolfo C, Trahair T, Sorrentino S, for the SIOPEN NB-SCI Study Group.
Spinal canal invasion in peripheral neuroblastic tumors – a siopen prospective study registry.
Congress of the International Society of Paediatric Oncology (SIOP), Washington, DC, USA, October 2017.
Abstract book, p. 120.

99. Ash S, Haupt R, Kraal K, Plantaz D, Wieczorek A, Kachanov D, Owens C, Trager C, De Bernardi B, Gandolfo C, Trahair T, Sorrentino S, for the SIOPEN NB-SCI Study Group.
Spinal canal invasion in peripheral neuroblastic tumors – report from the siopen prospective study registry
San Fransisco, USA, May 2018.
Abstract book, p..

G. OTHER PUBLICATIONS

1. Zeka F, Van Goethem A, Vanderheyden K, Demuynck F, Lammens T,
Decock A, Helsmoortel HH, Vermeulen J, Noguera R, Berbegall, Combaret V, Schleiermacher G, Laureys G, Schramm A, Schulte JH, Rahmann S, Bienertová-Vašků J, Mazánek P, Jeison M, Ash S, Hogarty MD,
Moreno-Smith M, Barbieri E, Shohet J, Berthold F, Speleman F, Fischer M,
De Preter K, Mestdagh P, Vandesompele J.
Circulating microRNA biomarkers for metastatic disease in neuroblastoma patients.
JCI Insight. 2017.
Submitted to publication. Journal without Impact Factor.